There is a total of 22 approved companies in the list of 32 which supply antibody testing.
Of the 22 approved companies 2 are from the US. Given they are short over there none will be imported here - leaving 20 left.
Of the remaining 20,all source test kits from Chinese manufacturers, however only 5, YES FIVE, are from the approved NMPA list of seven: Guangzhou Wondfo Biotech, Shanghai ZJ Bio-Tec, INNOVITA(Tangshan) Biological Technology, Bioscience (Chongqing) Diagnostic Technology, Xiamen Innodx Biotech Hecin Scientific, Nanjing Vazyme Medical Technology, Zhuhai Livzon Diagnostics. Only by being on this list, Chinese companies are allowed to make, sell, and export COVID-19 test kits overseas.
The remaining 5 companies are:
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
1
2019-nCoV Ab Test (Colloidal Gold)
POCT
Lateral Flow IgG/IgM
Aurora Future Education Group
Innovita (Tangshan) Biological Technology Co Ltd (China)
4-Apr-20
2
2019-nCoV Ab Test (Colloidal Gold)
POCT
Lateral Flow IgG/IgM
Endo X
Innovita (Tangshan) Biological Technology Co Ltd (China)
8-Apr-20
3
2019-nCoV Ab Test (Colloidal Gold)[/B][/B]
POCT
Lateral Flow IgG/IgM
TrendBio Pty Ltd
Innovita (Tangshan) Biological Technology Co Ltd (China)
11-Apr-20
4
SARS-CoV-2 Antibody Test (Lateral Flow Method)[/B][/B]
POCT
Lateral Flow IgG/IgM
Advangen International Pty Ltd
Guangzhou Wondfo Biotech Co Ltd (China)
25-Mar-20
5
SARS-CoV-2 Antibody Test (Lateral Flow Method)
POCT
Lateral Flow IgG/IgM
Tayler Dental Consulting Pty Ltd
Guangzhou Wondfo Biotech Co Ltd (China)
9-Apr-20
Of the remaining 5 companies ...
Tayler Dental Consulting will most likely not contribute anything (given they don't even have a website or contact number).
Aurora Future Education Group will most likely not contribute anything either (given they are an education group).
Of the remaining 3 companies ...
Only Cellmid (Advangen) have confirmed they have stock on Australia shores.
Only Cellmid have announced their tests are to be sold at all.
Only Cellmid had their TGA approval granted in March giving them more than two weeks of a head start to the next competitor.
Plus, the other two companies may be given supply restrictions as they're contesting over the same supplier for the same market.
Not to mention, Cellmid already have an import permit. The other two companies may not even have that yet given how recent their TGA approvals were.
So really everyone, when COVID-19 antibody testing kicks off in Australia to account for herd immunity and virus spread, which company will be primed to take full advantage in providing the country with globally tested and proven kits?
Probably Cellmid.
Once again, DYOR, and remember, down ramping to ACCUMULATE is a thing.
